Julius Clinical Research B.V.

Haematology and sickle cell disease

Julius Clinical Research B.V. is active in clinical research focused on sickle cell disease, with interest in disease mechanisms linked to red blood cell dysfunction and haemoglobin disorders.

  • Red blood cell sickling
  • Haemolytic anaemia
  • Oxygen transport

The sponsor’s research activity in this area also includes evaluation of treatment-related safety and cardiovascular monitoring through routine clinical assessments.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study of Mitapivat for Adults with Sickle Cell Disease

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands